TrialESMO open2022

Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113).

I Hartlapp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.